- Pharmacology
- Allergy, Immunology, and ENT
- Cardiology
- Emergency Medicine
- Endocrinology
- Adolescent Medicine
- Gastroenterology
- Infectious Diseases
- Neurology
- OB/GYN
- Practice Improvement
- Gynecology
- Respiratory
- Dermatology
- Mental, Behavioral and Development Health
- Oncology
- Rheumatology
- Sexual Health
- Pain
New rapid test to diagnose respiratory syncytial virus
Diagnosing respiratory syncytial virus is a challenge because its symptoms are similar to other respiratory illnesses.
Diagnosing respiratory syncytial virus (RSV) is a challenge because its symptoms are similar to other respiratory illnesses. A new diagnostic test, QuickVue RSV 10 (Quidel Corp), is available to help quickly diagnose RSV in children younger than 6 years old. The test is approved as an aid in the rapid diagnosis of acute RSV infection.
The dipstick test detects the RSV antigen directly from nasopharyngeal swab and aspirate/wash specimens. The same sample can be used to test for influenza using the QuickVue Influenza A+B test.
The US Food and Drug Administration (FDA) recommends confirming negative results with a cell culture. A negative result should not be used as the sole basis for treatment or other management decisions.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
